Company news

Dimerix Limited news in 2016

Dimerix Limited's news releases, calls and decks from 2016, newest first.

View company

Recruitment of Part A of Phase 2 Trial of DMX-200 Completed

December 5, 2016

Appointment of Chief Executive Officer

November 6, 2016

Update presentation - interim data

October 11, 2016

Positive interim analysis of DMX-200 phase II data

October 3, 2016

Appendix 4E

August 24, 2016

Response to ASX Price and Volume Query

August 15, 2016

Outcomes of DMX-200 pre-IND meeting with the FDA

August 1, 2016

Update for NASH Pre-Clinical Program

July 28, 2016

10 Patient Milestone Reached. On Track to Report Trial Data.

June 5, 2016

ARC Linkage Grant to progress discovery platform

May 6, 2016

DXB requests US FDA pre IND meeting - performance milestone

April 27, 2016

Dimerix Receives TGA Special Access Scheme Approval

April 18, 2016

Activity Report & Appendix 4C

March 30, 2016

SBN to undertake SPP

March 30, 2016

SBN: Proposed Investment in OMI

March 30, 2016

SBN: New Investments

March 30, 2016

Exciting New Oil and Gas Opportunity

March 30, 2016

Update on EP 389 Farmin

March 30, 2016

SBN: Convertible Note Agreement

March 30, 2016

Non-Renounceable Rights Issue Announcement and Appendix 3B

March 30, 2016

Half Year Accounts

March 30, 2016

Consolidation Announcement and Notice of General Meeting

March 30, 2016

Reply to ASX Price Query

March 30, 2016

Preliminary Final Report & Full Year Statutory Accounts

March 30, 2016

Company Update

March 30, 2016

Manufacturing Service Agreement

March 30, 2016

Receipt of US Patent Allowance for Chronic Kidney Disease

February 18, 2016

Dimerix Receives Orphan Designation

February 11, 2016

Trademark Application & Extension

February 10, 2016

Sun Biomedical to Acquire Dimerix Bioscience

February 10, 2016

Sun Biomedical Completes First Phase of Oraline Testing

February 10, 2016

SBN Invests In Technology Accelerator Program

February 10, 2016

Private Clinic Initiated for DMX200 Trial

February 10, 2016

Non-Renounceable Rights Issue Offer Document

February 10, 2016

Manujfacturing Partnership - Test Strips

February 10, 2016

Manufacturing Partnership

February 10, 2016

Manufacturing Agreement

February 10, 2016

Madrid Convention Trademark Applications

February 10, 2016

First Patient in Phase II Trial

February 10, 2016

Exclusive Negotiation Arrangement

February 10, 2016

End of Negotiation Period with Parvulus Suisse SA

February 10, 2016

Dimerix Shareholders Sign Sale Agreements with SBN

February 10, 2016

Dimerix Receives Aust Patent Grant for Combination Therapy

February 10, 2016

Convertible Note Update

February 10, 2016

Board and Company Secretary Changes

February 10, 2016

Asthma Research Agreement & Capital Raising

February 10, 2016

Appendix 4E & Financial Statements

February 10, 2016

Appendix 4D- Half Year Report

February 10, 2016

Appendix 4D & Half-Year Financial Statements

February 10, 2016

Acitivity Report & Appendix 4C

February 10, 2016

Decks in 2016